Function and regulatory mechanisms of the candidate tumor suppressor receptor Protein Tyrosine Phosphatase Gamma (PTPRG) in breast cancer cells

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 1937-1946

  Shu, Sherry T ^a   Sugimoto, Yasuro ^a,b   Liu, Suling ^a   Chang, Hsiang Lin ^a   Ye, Weiping ^a   Wang, Li Shu ^a   Huang, Yi Wen ^a   Yan, Pearlly ^a,b   Lin, Young C ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Cell cycle regulators; PTPG; Tumor suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE GAMMA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL STRAIN MCF 7; CELL VIABILITY; EPIGENETICS; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; IN VIVO STUDY; INTRACELLULAR SIGNALING; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; AZACITIDINE; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA METHYLATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HYDROXAMIC ACIDS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PHOSPHORYLATION; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5;

EID: 77955071133     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J and Mustelin TO: Protein tyrosine phosphatases in the human genome. Cell 117(6): 699-711, 2004.
2. Modi S, Seidman AD, Dickler M, Moasser M, D'Andrea G, Moynahan ME, Menell J, Panageas KS, Tan LK, Norton L and Hudis CA: A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. Breast Cancer Res Treat 90(2): 157-163, 2005
3. Kantarjian HM, Giles F, Gattermann N, Bhalla K, Alimena G, Palandri F, Ossenkoppele GJ, Nicolini FE, O'Brien SG, Litzow M, Bhatia R, Cervantes F, Haque A, Shou Y, Resta DJ, Weitzman A, Hochhaus A and le Coutre P: Nilotinib (formerly AMN107), a highly selective bcr-abl tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance. Blood 110(10): 3540-3546, 2007.
4. Mustelin T and Tasken K: Positive and negative regulation of T- cell activation through kinases and phosphatases. Biochem J 371(Pt 1): 15-27, 2003
5. Liu S, Sugimoto Y, Sorio C, Tecchio C and Lin YC: Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. Oncogene 23(6): 1256-1262, 2004.
6. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK and Moller NP: Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21(21): 7117-7136, 2001.
7. Jiang ZX and Zhang ZY: Targeting PTPs with small molecule inhibitors in cancer treatment. Cancer Metastasis Rev 27(2): 263-272, 2008.
8. Marzocchini R, Malentacchi F, Biagini M, Cirelli D, Luceri C, Caderni G and Raugei G: The expression of low molecular weight protein tyrosine phosphatase is up-regulated in 1,2- dimethylhydrazine-induced colon tumours in rats. Int J Cancer 122(7): 1675-1678, 2008.
9. Zhang SH, Liu J, Kobayashi R and Tonks NK: Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1. J Biol Chem 274(25): 17806-17812, 1999.
10. Motiwala T, Kutay H, Ghoshal K, Bai S, Seimiya H, Tsuruo T, Suster S, Morrison C and Jacob ST: Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer. Proc Natl Acad Sci USA 101(38): 13844-13849, 2004.
11. Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G and Fusco A: Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol 20(24): 9236-9246, 2000.
12. Tsukamoto T, Takahashi T, Ueda R, Hibi K, Saito H and Takahashi T: Molecular analysis of the protein tyrosine phosphatase gamma gene in human lung cancer cell lines. Cancer Res 52(12): 3506-3509, 1992.
13. Lubinski J, Hadaczek P, Podolski J, Toloczko A, Sikorski A, McCue P, Druck T and Huebner K: Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res 54(14): 3710-3713, 1994.
14. Zheng J, Kulp SK, Zhang Y, Sugimoto Y, Dayton MA, Govindan MV, Brueggemeier RW and Lin YC: 17 Beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Anticancer Res 20(1A): 11-19, 2000.
15. van Niekerk CC and Poels LG: Reduced expression of protein tyrosine phosphatase gamma in lung and ovarian tumors. Cancer Lett 137(1): 61-73, 1999.
16. Vezzalini M, Mombello A, Menestrina F, Mafficini A, Della Peruta M, van Niekerk C, Barbareschi M, Scarpa A and Sorio C: Expression of transmembrane protein tyrosine phosphatase gamma (PTPgamma) in normal and neoplastic human tissues. Histopathology 50(5): 615-628, 2007.
17. Khoury JD, Rassidakis GZ, Medeiros LJ, Amin HM and Lai R: Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma. Blood 104(5): 1580-1581, 2004.
18. Brady H, Desai S, Gayo-Fung LM, Khammungkhune S, McKie JA, O'Leary E, Pascasio L, Sutherland MK, Anderson DW, Bhagwat SS and Stein B: Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models. Cancer Res 62(5): 1439-1442, 2002.
19. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4): 402-408, 2001.
20. KiP1 degradation and anchorage independence by ras through the MAP kinase signaling pathway. Oncogene 15(6): 629-637, 1997.
21. Takai D and Jones PA: Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99(6): 3740-3745, 2002.
22. Lissandrini D, Vermi W, Vezzalini M, Sozzani S, Facchetti F, Bellone G, Mafficini A, Gentili F, Ennas MG, Tecchio C and sorio C: Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages. Blood 108(13): 4223-4231, 2006.
23. Sorio C, Melotti P, D'Arcangelo D, Mendrola J, Calabretta B, Croce CM and Huebner K: Receptor protein tyrosine phosphatase gamma, ptp gamma, regulates hematopoietic differentiation. Blood 90(1): 49-57, 1997.
24. Lamprianou S, Vacaresse N, Suzuki Y et al: Receptor protein tyrosine phosphatase gamma is a marker for pyramidal cells and sensory neurons in the nervous system and is not necessary for normal development. Mol Cell Biol 26(13): 5106-5119, 2006.
25. Shintani T, Maeda N and Noda M: Receptor-like protein tyrosine phosphatase gamma (RPTPgamma), but not PTPzeta/RPTPbeta, inhibits nerve-growth-factor-induced neurite outgrowth in PC12D cells. Dev Neurosci 23(1): 55-69, 2001.
26. Iuliano R, Trapasso F, Le Pera I, Schepis F, Sama I, Clodomiro A, Dumon KR, Santoro M, Chiariotti L, Viglietto G and Fusco A: An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. Cancer Res 63(4): 882-886, 2003.
27. Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Pattarozzi A, Bajetto A, Trapasso F, Fusco A and Schettini G: The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC C13 thyroid cell proliferation. Mol Endocrinol 15(10): 1838-1852, 2001.
28. Harris DL and Joyce NC: Protein tyrosine phosphatase, PTP1B, expression and activity in rat corneal endothelial cells. Mol Vis 13: 785-796, 2007
29. Pulido R, Zuniga A and Ullrich AP: PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J 17(24): 7337-7350, 1998.
30. Ghoshal K, Datta J, Majumder S, Bai S, Kutay H, Motiwala T and Jacob ST: 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol 25(11): 4727-4741, 2005.
31. Mei S, Ho AD and Mahlknecht U: Role of histone deacetylase inhibitors in the treatment of cancer (review). Int J Oncol 25(6): 1509-1519, 2004.